Pignagnoli Agosti Marcello's Form 4 filing
Takeda Pharmaceutical Co Ltd (TAK) · filed Jul 6, 2026
- Accession no.
- 0001395064-26-000251
- Filed
- Jul 6, 2026, 6:04 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pignagnoli Agosti MarcelloCIK 0001977817 | Officer (Head, Strat. & Port. Dev.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | American Depositary Shares | AGrant or awardAcquired | +27,586 | $0.00 | $0 | 199,934 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.